EUS Procedures Using RIVOS™ EUS Access Device

NCT07696572 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2026-07-10

No results posted yet for this study

Summary

This is a prospective study of patients undergoing EUS procedures using the RIVOS™ EUS access device.

Conditions

  • Pancreatic Fluid Collections
  • Biliary Obstruction
  • Pancreatic Duct Obstruction
  • Chronic Pancreatitis
  • Pancreatic Cancer Non-resectable

Interventions

DEVICE

EUS-guided intervention using the RIVOS™ EUS access device

EUS-guided intervention using the RIVOS™ EUS access device

Sponsors & Collaborators

  • Orlando Health, Inc.

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-31
Primary Completion
2027-07-31
Completion
2027-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07696572 on ClinicalTrials.gov